Hyaluronic acid leader, short and medium term by virtue of the "Hi system column + long-lasting BONIDA" support, long-term look at the "hyaluronic acid + Botox double injection and closely follow the mainstream aesthetic slimming fat reduction". The company's self-developed and approved products include Emmi, BONIDA, Aveline, Hi-Body, and Emmi One Plus One. The company is the first domestic enterprise to obtain the certificate of registration of sodium hyaluronate for injection and medical device products approved by the FDA for facial soft tissue repair. Total share capital of 21,600,000 shares, 4,937.87 outstanding A shares, earnings per share of 4.5100 yuan.
Two, Hao Hai Biotechnology
Internationalized medical device platform type enterprise, ophthalmology revenue accounted for 44%, medical aesthetics accounted for 19%, orthopaedics accounted for 22%, anti-adhesion and hemostasis accounted for 12%, of which hyaluronic acid product sales ranked at the forefront of the market, the core product Haimin, open performance growth space. Total share capital of 17,700,000 shares, 9,487.87 shares outstanding, earnings per share of 1.3000 yuan.
Three, Yifan Pharmaceutical
October 30, 2019 the company said in the interactive platform, the company has hyaluronic acid products, but the product operation is the company's non-core main business, the current revenue accounted for a small percentage of the company's new business. Total share capital of 123,400 shares, circulation of A shares of 84,600 shares, earnings per share of 0.8000 yuan.
Four, DZH
The company's hyaluronic acid products are self-developed. Total share capital of 224,100 shares, 222,000 outstanding A shares, earnings per share of 0.1282 yuan.
V. Dongfulong
The company's pre-filled production line can be used for the production and packaging of various sterile products such as vaccines, monoclonal antibody, small molecule heparin, insulin, hyaluronic acid and so on. The total share capital is 62,800,000 shares, with 42,800,000 A shares outstanding, and earnings per share is $0.7400.
Main Ingredients:
Hyaluronic acid is an acidic mucopolysaccharide, which was first isolated from the vitreous humor of the cow's eye in 1934 by Meyer et al, professors of ophthalmology at Columbia University. Hyaluronic acid with its unique molecular structure and physicochemical properties in the body shows a variety of important physiological functions, such as lubrication of joints, regulating the permeability of blood vessel walls, regulating protein, water electrolyte diffusion and operation, and promoting wound healing.
Name:
Hyaluronic acid, also known as hyaluronic acid, hyaluronic acid hyal-means glass-like, shiny and transparent, while uronic acid refers to glucuronic acid, and uronic acid does not have any relationship.